Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Alisertib

EU orphan designation number: EU/3/12/1074   
Active ingredient: Alisertib
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: Takeda Development Centre Europe Ltd.
61 Aldwych, London WC2B 4AE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/12/2012 Centralised Orphan - Designation EMA/OD/104/12 (2012)9393 of 06/12/2012
12/11/2013 Centralised Orphan - Change of address